Rita Jain - May 20, 2022 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role: EVP, Chief Medical Officer, Director
Signature: /s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol: CCXI
Transactions as of: May 20, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/24/2022, 07:27 PM
Previous filing: Mar 29, 2022
Next filing: Oct 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCXI	Common Stock	Options Exercise	$0	+7.73K	+27.46%	$0.00	35.9K	May 20, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCXI	Restricted Stock Units	Options Exercise		-7.73K	-100%		0	May 20, 2022	Common Stock	7.73K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.
F2	Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F3	100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.